Amgen
–
Washington, DC, 20001
... for clinical development and clinical trial designs with cross functional input, including biostatistics, observational research and patient reported outcomes in Phase 1,2 and/or 3 clinical trials Knowledge of Good Clinical Practices (GCP), FDA and ... - May 09